75 related articles for article (PubMed ID: 15733365)
1. [Relationship between the expression of murine double minute 2 oncogene and non-Hodgkin lymphoma in childhood].
Liu Z; Long GF; Han YL; Wei HY
Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):928-31. PubMed ID: 15733365
[TBL] [Abstract][Full Text] [Related]
2. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.
Møller MB; Nielsen O; Pedersen NT
Mod Pathol; 1999 Nov; 12(11):1010-6. PubMed ID: 10574597
[TBL] [Abstract][Full Text] [Related]
3. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.
Maestro R; Gloghini A; Doglioni C; Gasparotto D; Vukosavljevic T; De Re V; Laurino L; Carbone A; Boiocchi M
Blood; 1995 Jun; 85(11):3239-46. PubMed ID: 7756655
[TBL] [Abstract][Full Text] [Related]
4. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of suppressor of cytokines signalling-3 mRNA expression from patients with non-Hodgkin lymphoma under chemotherapy.
Attia FM; Hassan AM; El-Maraghy NN; Ibrahium GH
Cancer Biomark; 2011-2012; 11(1):41-7. PubMed ID: 22820139
[TBL] [Abstract][Full Text] [Related]
6. Expression of BIRC7 protein and mRNA in non-Hodgkin's lymphoma.
Wu H; Ma Y; Zhu Y; Shen Y; Gu C; Ye Z; Lin H
Leuk Lymphoma; 2006 Jun; 47(6):1110-6. PubMed ID: 16840203
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of Livin expression in non-Hodgkin's lymphoma].
Gao JM; Wang X; Liu XQ; Ge XL; Ding M; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):385-90. PubMed ID: 20416174
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
10. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
11. mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.
Taubert H; Koehler T; Meye A; Bartel F; Lautenschläger C; Borchert S; Bache M; Schmidt H; Würl P
Mol Med; 2000 Jan; 6(1):50-9. PubMed ID: 10803408
[TBL] [Abstract][Full Text] [Related]
12. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
[TBL] [Abstract][Full Text] [Related]
14. c-myc mRNA expression in non-Hodgkin's lymphomas.
Fellbaum C; Radaszkiewicz T; Ruhri C; Pütz B; Lehmacher W; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):61-8. PubMed ID: 1352077
[TBL] [Abstract][Full Text] [Related]
15. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
[TBL] [Abstract][Full Text] [Related]
16. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.
Halatsch ME; Schmidt U; Unterberg A; Vougioukas VI
Anticancer Res; 2006; 26(6B):4191-4. PubMed ID: 17201132
[TBL] [Abstract][Full Text] [Related]
17. No Influence of bcl-2, p53, and p21waf1 protein expression on the outcome of pediatric Hodgkin lymphomas.
Chabay P; Pesce P; De Matteo E; Lombardi MG; Rey G; Preciado MV
J Pediatr Hematol Oncol; 2006 Sep; 28(9):552-8. PubMed ID: 17006259
[TBL] [Abstract][Full Text] [Related]
18. Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB
Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral blood.
Han MH; Eom HS; Park WS; Yun T; Park S; Kim HJ; Jeon CH; Kong SY
Leuk Res; 2010 Sep; 34(9):1127-31. PubMed ID: 20036422
[TBL] [Abstract][Full Text] [Related]
20. [ZO-1 gene methylation status and its clinical significance in children with non-Hodgkin lymphoma].
Diao YQ; Qu F; Yang MJ; Meng JH; Zhu XL; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):619-23. PubMed ID: 24927439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
